News
ICUI
96.90
+1.06%
1.02
Weekly Report: what happened at ICUI last week (0408-0412)?
Weekly Report · 4d ago
Weekly Report: what happened at ICUI last week (0401-0405)?
Weekly Report · 04/08 09:10
Analysts Forecast 14% Gains Ahead For IJS
NASDAQ · 04/05 10:52
FDA: HAS IDENTIFIED SMITHS MEDICAL ASD RECALL OF PNEUPAC PARAPAC PLUS 300 AND 310 VENTILATOR KITS AS A CLASS I RECALL
Reuters · 04/04 14:57
FDA: SMITHS MEDICAL ASD RECALLED 2,906 PNEUPAC PARAPAC PLUS 300 AND 310 VENTILATOR KITS IN THE U.S.
Reuters · 04/04 14:57
FDA: SMITHS MEDICAL ASD PNEUPAC PARAPAC PLUS 300 AND 310 VENTILATOR KITS RECALL IS A CORRECTION, NOT A PRODUCT REMOVAL
Reuters · 04/04 14:57
U.S. FDA: SMITHS MEDICAL ASD RECALLS PNEUPAC PARAPAC PLUS300 AND 310 VENTILATOR KITS FOR MALFUNCTION
Reuters · 04/04 14:57
Weekly Report: what happened at ICUI last week (0325-0329)?
Weekly Report · 04/01 09:10
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
ICU Medical, Inc. (NASDAQ:ICUI) uses debt to fund its business. The company had US$1.63b in debt in December 2023. Its balance sheet shows it has a high level of debt, but is ICU Medical a risky investment? We look at the company's balance sheet to see if its debt is making the company risky. ICu Medical's debt to EBITDA ratio is high, but the company is able to convert debt to free cash flow.
Simply Wall St · 03/31 12:50
Weekly Report: what happened at ICUI last week (0318-0322)?
Weekly Report · 03/25 09:10
Weekly Report: what happened at ICUI last week (0311-0315)?
Weekly Report · 03/18 09:10
Weekly Report: what happened at ICUI last week (0304-0308)?
Weekly Report · 03/11 09:10
Chief Operating Officer Of ICU Medical Sold 100% Of Their Shares
ICU Medical, Inc. Insider Christian Voigtlander sold US$1.5m worth of stock at a price of US$107 per share. The recent sale is a negative sign for shareholders of the company. In the last year ICU Medical insiders didn't buy any company stock. The CEO of ICu Medical owns 6.1% of the Company. You can see the insider transactions of ICU medical over the last decade.
Simply Wall St · 03/09 14:25
Weekly Report: what happened at ICUI last week (0226-0301)?
Weekly Report · 03/04 09:10
ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference
ICU Medical, Inc. Will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024. Company management will also participate in one-on-one meetings. ICU Medical is a leader in the development, manufacture and sale of innovative medical products.
Barchart · 03/01 16:15
The Cooper Companies: I Still Don't See Much Upside
Seeking Alpha · 03/01 12:17
ICU Medical Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
ICU Medical's revenue exceeded analyst estimates by 1.3%. The company's shares are up 6.1% from a week ago. Revenue is forecast to grow 2.4% in the next 3 years. ICU Medical missed analyst estimates for earnings per share by 5.6%.
Simply Wall St · 03/01 11:43
ICU Medical Board Member Resigns, Retires from Smiths Group
TipRanks · 02/29 13:42
Zacks.com featured highlights include ICU Medical and Ardmore Shipping
NASDAQ · 02/28 14:02
ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
Oppenheimer boosted the price target for Tarsus Pharmaceuticals, Inc. Needham increased Axon Enterprise's price target from $240 to $315 on Tuesday. Mizuho slashed the price targets for Essex Property Trust and Sterling Infrastructure. Barclays raised Ecolab's share price from Equal-Weight to Overweight.
Benzinga · 02/28 13:07
More
Webull provides a variety of real-time ICUI stock news. You can receive the latest news about Icu Medical through multiple platforms. This information may help you make smarter investment decisions.
About ICUI
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.